Correction to: Leukemia (2008) 22, 1767–1772; doi:10.1038/leu.2008.159; published online 26 June 2008
Since the publication of their paper, the authors have identified an error in the 5-year overall survival rates for the four risk groups, which were listed incorrectly in the abstract, in the second paragraph of the Results section and in Table 4. The correct 5-year OS rates are 95, 64, 46 and 22%, respectively. A revised version of Table 4 is reproduced below.
The authors apologize for any inconvenience caused.
Additional information
The online version of the original article can be found at 10.1038/leu.2008.159
Rights and permissions
About this article
Cite this article
Jakob, C., Sterz, J., Liebisch, P. et al. Erratum: Incorporation of the bone marker carboxy-terminal telopeptide of type-1 collagen improves prognostic information of the International Staging System in newly diagnosed symptomatic multiple myeloma. Leukemia 22, 1812 (2008). https://doi.org/10.1038/leu.2008.201
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2008.201
